Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Spondylitis, Ankylosing 1Psoriasis 1Osteosarcoma 1Neuroblastoma 1Lung Neoplasms 1Crohn Disease 1Chickenpox 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Arthritis 1

Interventions

Etanercept 12Adalimumab 12Infliximab 7golimumab 4Tumor Necrosis Factor Inhibitors 4Certolizumab Pegol 4Abatacept 4tofacitinib 2tocilizumab 2Rituximab 2Antirheumatic Agents 2Vitamin D 1Vaccines 1Syringes 1Surveys and Questionnaires 1Standard of Care 1Sodium Chloride 1Saline Solution 1Radioimmunodetection 1Prednisone 1Practice Guidelines as Topic 1Phlebotomy 1Observation 1Nivolumab 1Methotrexate 1Methods 1Lysine Acetyltransferase 5 1Licensure 1Leflunomide 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Arthritis, Rheumatoid × Herpes Zoster Vaccine × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡